Cyclosporine Capsules, Modified and Mogamulizumab-kpkc Intravenous
Determining the interaction of Cyclosporine Capsules, Modified and Mogamulizumab-kpkc Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: cyclosporine
Brand name: Gengraf, Neoral, Sandimmune, Sandimmune
Synonyms: Cyclosporine (oral/injection), CycloSPORINE (Systemic)
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cyclosporine Capsules, Modified-Molindone
- Cyclosporine Capsules, Modified-Mometasone (Oral Inhalation)
- Cyclosporine Capsules, Modified-Mometasone and Formoterol
- Cyclosporine Capsules, Modified-Mometasone and formoterol Inhalation
- Cyclosporine Capsules, Modified-Mometasone Cream
- Cyclosporine Capsules, Modified-Mometasone Furoate
- Mogamulizumab-kpkc Intravenous-Cyclosporine Injection
- Mogamulizumab-kpkc Intravenous-Cyclosporine Oral Solution
- Mogamulizumab-kpkc Intravenous-Cyclosporine Oral Solution, Modified
- Mogamulizumab-kpkc Intravenous-Cyclosporine Oral, Intravenous
- Mogamulizumab-kpkc Intravenous-Cyclosporine oral/injection
- Mogamulizumab-kpkc Intravenous-Cyclosporine Soft Gelatin Capsules